Dr. Meghan Riddle, MD
Claim this profileButler Hospital
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
7 reported clinical trials
14 drugs studied
Area of expertise
1Alzheimer's Disease
ApoE positive
ApoE negative
2Mild Cognitive Impairment
ApoE positive
ApoE negative
Affiliated Hospitals
Clinical Trials Meghan Riddle, MD is currently running
CT1812
for Early Alzheimer's Disease
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Recruiting0 awards Phase 2
Remternetug
for Alzheimer's Disease
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo. Participation could last up to 255 weeks including screening, a double-blind treatment period, and a double-blind observation period. In addition, eligible participants who receive placebo during the double-blind treatment period may choose to extend their study participation to receive open-label remternetug in an extension period.
Recruiting1 award Phase 31 criteria
More about Meghan Riddle, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Meghan Riddle, MD has experience with
- Placebo
- Emtricitabine
- Donanemab
- Aducanumab
- Amyvid
- MK-6240
Breakdown of trials Meghan Riddle, MD has run
Alzheimer's Disease
Mild Cognitive Impairment
Alzheimer's disease
Neuro-Oncology
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Meghan Riddle, MD specialize in?
Meghan Riddle, MD focuses on Alzheimer's Disease and Mild Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved ApoE positive patients, or patients who are ApoE negative.
Is Meghan Riddle, MD currently recruiting for clinical trials?
Yes, Meghan Riddle, MD is currently recruiting for 3 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Meghan Riddle, MD has studied deeply?
Yes, Meghan Riddle, MD has studied treatments such as Placebo, Emtricitabine, Donanemab.
What is the best way to schedule an appointment with Meghan Riddle, MD?
Apply for one of the trials that Meghan Riddle, MD is conducting.
What is the office address of Meghan Riddle, MD?
The office of Meghan Riddle, MD is located at: Butler Hospital, Providence, Rhode Island 02906 United States. This is the address for their practice at the Butler Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.